CTRI/2020/06/026194Other未知
A randomized, double blind, placebo controlled, comparative study to investigate the efficacy of N-acetylcysteine in COVID-19 patients with standard therapy.
Index Medical College and research centre Indore0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- Other
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •patients of both genders who aged between 10 years to 55 years with confirmation of COVID-19 infection through RT-PCR test. Mild to moderate severity of disease who are willing to participate in study by giving written informed consent.
排除标准
- •seriously ill patients requiring ventilators support.
- •Children below 10 years, adults > 55 years of age.
研究者
相似试验
尚未招募
2 期
safety and anti-aging efficacy of orally administered herbal extract formulations in elderly healthy individualsCTRI/2022/09/045375Pharmanza Herbal
进行中（未招募）
1 期
A double-blind, placebo controlled, randomized, comparative, mono-centre trial to assess the effects on the androgen metabolism and its effects on biochemical parameters, mood, fat, muscle and bone of continuous supplementation with dehydroepiandrosterone in women using a monophasic contraception containing drospirenone and ethinylestradiol - AMUSABiochemical disturbances (androgens, lipids, bone markers, endocrine) and mood disturbances caused by the use of Oral Contraception (OC).EUCTR2007-003788-28-BEPantarhei Bioscience B.V.99
进行中（未招募）
1 期
A double-blind, placebo controlled, randomized, comparative, mono-centre trial to assess the impact of a monthly administration of 50.000 IU of Vitamin D during 6 months on Vitamin D level in healthy young adult volunteers. - D-plusEUCTR2010-022454-17-BEniversity of Liège- Dpt de Médecine Générale
已完成
2 期
Effects of concomitant treatment with an androgen on androgen metabolism, biochemical parameters, mood, fat, muscle and bone in women using an oral contraceptioISRCTN06414473Pantarhei Bioscience BV (Netherlands)100
进行中（未招募）
1 期
A double-blind, placebo controlled, randomised, comparative 2-way crossover study to determine the effect of concomitant treatment with dehydroepiandrosterone (50 mg) on sexual arousability and the vascular component of the sexual arousal response during self-induced erotic fantasy and visual sexual stimulation in women using oral contraception (150 mcg levonorgestrel and 30 mcg ethinylestradiol or 3 mg drospirenone and 30 mcg ethinylestradiol) - ARC studyEUCTR2007-000013-10-NLPantarhei Bioscience B.V.82